GATA2
Clinical trials for GATA2 explained in plain language.
Never miss a new study
Get alerted when new GATA2 trials appear
Sign up with your email to follow new studies for GATA2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune disorder: can a transplant reset the Body's defenses?
Disease control Recruiting nowThis study is testing whether a stem cell transplant from a matched donor can treat GATA2 deficiency, a rare genetic disorder that causes serious infections and can lead to blood cancers. The transplant aims to replace the patient's faulty bone marrow with healthy donor cells to …
Matched conditions: GATA2
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Hunting the genetic roots of rare immune diseases
Knowledge-focused Recruiting nowThis study aims to discover the specific genes that cause certain inherited immune disorders and understand how they affect health and family risk. It involves patients and their family members who have or are suspected of having these genetic conditions. Participants provide blo…
Matched conditions: GATA2
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC